Screener
Ocular Therapeutix OCUL Gross margin
Gross margin at other companies
Other financials
Where this comes from
Calculated from Ocular Therapeutix’s reported figures.
Based on trailing twelve months.
The source filing: Ocular Therapeutix’s 10-Q, filed May 5, 2026. Open the filing →
- Filed
- May 5, 2026, 7:28 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001104659-26-055256
FAQ
- What is Ocular Therapeutix's gross margin?
- Ocular Therapeutix (OCUL) reported gross margin of 87.2% in Q1 2026.
- How has Ocular Therapeutix's gross margin changed year-over-year?
- Ocular Therapeutix's gross margin decreased by 3.8% year-over-year, from 90.7% to 87.2%.
- What is the long-term trend for Ocular Therapeutix's gross margin?
- Over 5 years (2020 to 2025), Ocular Therapeutix's gross margin has grown at a -0.2% compound annual growth rate (CAGR), from 88% to 87.3%.
- What does gross margin mean?
- Gross profit (revenue minus cost of revenue) as a percentage of revenue, on a trailing-twelve-month basis. Measures how much of each sales dollar survives the direct cost of producing the goods or services sold.
Ask your AI about Ocular Therapeutix's gross margin.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude